| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8231667 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 5 Pages |
Abstract
The presence of tumor hypoxia is a major negative factor in limiting the curability of tumors by SABR at radiation doses that are tolerable to surrounding normal tissues. However, this negative effect of hypoxia could be overcome by the addition of clinically tolerable doses of the hypoxic cell radiosensitizer etanidazole.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
J. Martin D.Phil., Maximilian M.D., Ph.D., Billy W. M.D., Ph.D.,